Compound Monograph
Harmine
Harmine is a beta-carboline alkaloid and reversible MAO-A inhibitor central to the activity of ayahuasca.
Classification
Harmine is a beta-carboline alkaloid, part of the alkaloids class. Nitrogen-containing, often bitter and physiologically potent compounds — the group behind many of the strongest plant medicines and poisons.
Where Does It Come From? (5)
Harmine is a naturally occurring beta-carboline alkaloid, found in Banisteriopsis caapi, Syrian rue, Passionflower and 2 other sources. It is flagged as moderately toxic.
Research & Evidence
Harmine is a beta-carboline (harmala) alkaloid and one of the principal alkaloids of the ayahuasca vine Banisteriopsis caapi and of Syrian rue. Its key pharmacological action is reversible inhibition of monoamine oxidase A (MAO-A); in traditional ayahuasca preparations this is what enables orally consumed DMT to become active. Harmine has a long history under names such as telepathine and banisterine, and it has attracted modern research interest both for its role in ayahuasca and as a chemical probe in studies of enzymes such as DYRK1A.
Monoamine oxidase (MAO) inhibition
Among plant-derived MAO inhibitors, harmine is one of the most potent ever measured. It’s a reversible, competitive inhibitor selective for MAO-A, with a reported binding constant (Ki) near 5 nM — nanomolar potency, on the order of a thousand times stronger than typical flavonoid inhibitors — while barely touching MAO-B 1Reference 1Inhibition of monoamine oxidase A by beta-carboline derivativesView study →. That MAO-A selectivity is exactly what lets harmine (and the Syrian rue and ayahuasca vine that carry it) shield orally ingested DMT from first-pass breakdown. See the natural MAO inhibitors guide for how it compares with other plants.
Toxicity & Safety
As an MAO-A inhibitor, harmine carries the interaction risks typical of that class: combining it with serotonergic drugs or tyramine-rich foods can produce dangerous reactions, including serotonin toxicity. It commonly causes nausea and vomiting and should be treated with caution by anyone on other medications.
References
- Kim, H., Sablin, S. O., & Ramsay, R. R. (1997). Inhibition of monoamine oxidase A by beta-carboline derivatives. Archives of Biochemistry and Biophysics, 337(1), 137-142. https://pubmed.ncbi.nlm.nih.gov/8990278/